5
Elantas Beck India Ltd
ELANTAS NSE
Elantas Beck India Ltd
CommoditiesNSE: ELANTAS BSE: 500123 Chemicals & Petrochemicals
Key Fundamentals
MicrocapSpecialty ChemicalsChemicalsMarket Cap
₹7,332 Cr
Volatility
Moderate
P/E Ratio
50.39
EBITDA
₹220 Cr
Return on Equity
14.66%
Debt to Equity
0
Book Value
₹1,271.75
52W High
₹10,965
52W Low
₹8,900
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Elantas Beck India Ltd insights
29 extracted metrics + investor summaries across FY14–FY25.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Company is almost debt free.
- Company has delivered good profit growth of 19.1% CAGR over last 5 years
Weaknesses
1- Stock is trading at 7.30 times its book value
Growth Rate
Revenue Growth
11.53% ↗
Net Income Growth
5.87% ↗
Cash Flow Change
101.06% ↗
ROE
-8.94% ↘
ROCE
-7.61% ↘
EBITDA Margin (Avg.)
-0.81% ↗
AI Analysis — Bull vs Bear
anthropic claude-opus-4.6 43d agoAI opinion · based on fundamentals
Risk medium
Elantas Beck India is a high-quality, debt-free specialty chemicals compounder with 19% profit CAGR over 5 years, but trades at a steep 52.6x PE and 7.6x book value with decelerating growth in the TTM period. At current valuations, the risk-reward is balanced and warrants patience for a better entry point.
Bull Case 8
- Company is virtually debt-free, providing strong balance sheet resilience and financial flexibility in a cyclical commodities environment
- Compounded profit growth of 19% CAGR over 5 years demonstrates consistent earnings power and operational leverage
- 10-year stock CAGR of 20% reflects long-term wealth creation track record for patient investors
- ROE has averaged 17% over 10 years, indicating efficient capital allocation and high return on shareholder equity
- 3-year stock CAGR of 16% outperforms broader market indices despite recent correction, showing relative strength
- Compounded sales growth of 17% over 5 years shows strong revenue momentum driven by industrial demand for electrical insulation products
- Market cap of Rs 7,823 crore positions it as a mid-cap with adequate liquidity and room for institutional participation
- 10-year compounded profit growth of 13% is well above nominal GDP growth, indicating structural market share gains
Bear Case 8
- PE ratio of 52.6x is extremely elevated for a commodities-adjacent business, leaving minimal margin of safety
- Price-to-book of 7.61x is steep and implies market is pricing in aggressive future growth that may not materialize
- 1-year stock return of -2% signals near-term de-rating and waning investor enthusiasm at current levels
- TTM profit growth has decelerated to 8% from 18% 3-year CAGR, suggesting margin compression or demand slowdown
- Dividend yield of just 0.08% offers negligible income support, providing no downside cushion in a correction
- ROE has declined from 18% (3-year) to 16% (last year), indicating possible deterioration in return profile
- Zero analyst coverage means no institutional consensus or price targets to anchor valuation expectations
- TTM sales growth of 11% has slowed from 17% 5-year CAGR, pointing to possible volume or pricing headwinds in raw material inputs
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
anthropic claude-opus-4.6 43d ago Positives 3
- ₹56 Cr Ankleshwar capacity expansion Jun 02
Board approved ₹56 crore investment to add 11,000 MT/year manufacturing capacity at Ankleshwar, aimed at improving flexibility and supply reliability.
- Strong Q4FY26 financial results May 12
Q4FY26 revenue came in at ₹22,216.93 lakhs with net profit of ₹3,108.43 lakhs; full-year FY26 net profit stood at ₹14,777.98 lakhs.
- ₹7.50 dividend, AGM resolutions passed May 13
70th AGM held on 12 May 2026 passed all 6 resolutions including a Rs. 7.50 per share dividend and key board appointments.
TL;DR: Elantas Beck India is in a solid growth phase — the ₹56 crore capex to add 11,000 MT capacity signals confidence in medium-term demand, while Q4FY26 profitability and a healthy dividend reinforce financial strength. No visible headwinds emerged in the recent news cycle. The trend is improving with both organic investment and steady shareholder returns pointing to continued momentum.
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 169 | 173 | 163 | 174 | 177 | 191 | 184 | 197 | 206 | 210 | 217 | 215 | 222 |
| Expenses | 134 | 138 | 126 | 138 | 139 | 153 | 150 | 162 | 166 | 170 | 169 | 170 | 179 |
| Operating Profit | 36 | 35 | 37 | 36 | 38 | 39 | 33 | 35 | 40 | 40 | 47 | 45 | 43 |
| OPM % | 21% | 20% | 23% | 20% | 21% | 20% | 18% | 18% | 20% | 19% | 22% | 21% | 20% |
| Other Income | 8 | 15 | 12 | 17 | 15 | 17 | 12 | 10 | 9 | 18 | 7 | 14 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 5 | 5 | 6 | 6 | 6 |
| PBT | 40 | 47 | 47 | 49 | 49 | 52 | 42 | 40 | 44 | 53 | 49 | 53 | 40 |
| Tax % | 26% | 25% | 25% | 25% | 25% | 20% | 25% | 26% | 26% | 26% | 25% | 25% | 23% |
| Net Profit | 30 | 35 | 35 | 37 | 37 | 42 | 31 | 30 | 33 | 39 | 36 | 39 | 31 |
| EPS in Rs | 37.91 | 44.68 | 43.93 | 46.67 | 46.56 | 52.79 | 39.19 | 37.51 | 41.46 | 49.56 | 45.74 | 49.66 | 39.2 |
Profit & Loss
| Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 341 | 344 | 365 | 383 | 409 | 394 | 383 | 522 | 645 | 680 | 749 | 848 | 864 |
| Expenses | 299 | 282 | 287 | 304 | 344 | 340 | 313 | 444 | 535 | 537 | 604 | 676 | 689 |
| Operating Profit | 42 | 62 | 79 | 78 | 65 | 54 | 70 | 78 | 110 | 143 | 144 | 172 | 175 |
| OPM % | 12% | 18% | 22% | 20% | 16% | 14% | 18% | 15% | 17% | 21% | 19% | 20% | 20% |
| Other Income | 8 | 6 | 8 | 9 | 31 | 18 | 22 | 25 | 32 | 53 | 55 | 48 | 42 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 5 | 6 | 5 | 6 | 7 | 7 | 12 | 12 | 12 | 12 | 15 | 21 | 22 |
| PBT | 45 | 62 | 81 | 81 | 89 | 64 | 80 | 91 | 129 | 184 | 183 | 199 | 195 |
| Tax % | 30% | 32% | 33% | 32% | 26% | 22% | 23% | 27% | 24% | 25% | 24% | 26% | — |
| Net Profit | 32 | 42 | 54 | 55 | 66 | 50 | 62 | 67 | 98 | 137 | 140 | 148 | 146 |
| EPS in Rs | 39.87 | 52.68 | 68.73 | 69.48 | 82.99 | 62.51 | 77.9 | 84.36 | 123 | 173 | 176 | 186 | 184 |
| Div. Payout % | 11% | 9% | 7% | 6% | 5% | 8% | 6% | 6% | 4% | 3% | 4% | 4% | — |
Balance Sheet
| Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 128 | 164 | 214 | 270 | 331 | 376 | 434 | 497 | 591 | 724 | 859 | 1,000 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 57 | 64 | 70 | 70 | 76 | 72 | 95 | 114 | 119 | 149 | 148 | 158 |
| Total Liabilities | 192 | 236 | 291 | 348 | 415 | 456 | 536 | 618 | 717 | 881 | 1,015 | 1,166 |
| Fixed Assets | 45 | 45 | 36 | 40 | 70 | 110 | 103 | 98 | 98 | 99 | 223 | 240 |
| CWIP | 1 | 0 | 5 | 15 | 0 | 10 | 18 | 19 | 13 | 17 | 19 | 8 |
| Investments | 30 | 64 | 109 | 139 | 174 | 160 | 218 | 261 | 356 | 517 | 379 | 592 |
| Other Assets | 116 | 126 | 140 | 154 | 171 | 176 | 198 | 240 | 250 | 247 | 395 | 326 |
| Total Assets | 192 | 236 | 291 | 348 | 415 | 456 | 536 | 618 | 717 | 881 | 1,015 | 1,166 |
Cash Flow
| Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 31 | 46 | 56 | 51 | 33 | 48 | 79 | 29 | 83 | 133 | 63 | 127 |
| Investing | 19 | -42 | -51 | -45 | -32 | -40 | -69 | -33 | -76 | -132 | 78 | -194 |
| Financing | -51 | -4 | -5 | -5 | -4 | -5 | -4 | -4 | -5 | -5 | -5 | -6 |
| Net Cash Flow | -2 | 0 | 0 | 2 | -3 | 4 | 6 | -8 | 2 | -3 | 136 | -74 |
| Free Cash Flow | 27 | 40 | 51 | 31 | 10 | 36 | 63 | 37 | 86 | 121 | -82 | 96 |
| CFO/OP | 107 | 107 | 104 | 96 | 80 | 118 | 136 | 60 | 103 | 120 | 71 | 97 |
Ratios
| Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 53 | 59 | 53 | 70 | 75 | 57 | 67 | 61 | 58 | 55 | 62 | 60 |
| Inventory Days | 84 | 85 | 100 | 75 | 74 | 77 | 89 | 95 | 73 | 68 | 78 | 71 |
| Days Payable | 55 | 64 | 73 | 73 | 71 | 56 | 103 | 86 | 67 | 81 | 76 | 61 |
| Cash Conversion Cycle | 82 | 80 | 80 | 71 | 78 | 77 | 54 | 70 | 64 | 41 | 64 | 70 |
| Working Capital Days | 58 | 55 | 55 | 62 | 69 | 59 | 46 | 57 | 48 | 33 | 56 | 56 |
| ROCE % | 35% | 40% | 41% | 33% | 23% | 18% | 19% | 17% | 22% | 28% | 23% | 21% |
Documents
1
Board Meeting Intimation for Board Meeting Scheduled On Tuesday, 12Th May, 2026
30 Apr - Board meeting on 12 May 2026 to approve Q4 FY2026 unaudited financial results; trading window closed from 1 April. 30 Apr - Board meeting on 12 May 2026 to approve Q4 FY2026 unaudited financial results; trading window closed from 1 April.
2
Board Meeting Intimation for Board Meeting Scheduled On Tuesday, 12Th May, 2026
30 Apr - Board meeting on 12 May 2026 to approve Q4 FY2026 unaudited financial results; trading window closed from 1 April. 30 Apr - Board meeting on 12 May 2026 to approve Q4 FY2026 unaudited financial results; trading window closed from 1 April.
3
Announcement under Regulation 30 (LODR)-Newspaper Publication
19 Apr - Newspaper Publication of Notice of 70th Annual General Meeting, remote e-voting and other related information. 19 Apr - Newspaper Publication of Notice of 70th Annual General Meeting, remote e-voting and other related information.
5
Business Responsibility and Sustainability Reporting (BRSR)
18 Apr - ELANTAS Beck India submitted its FY2025 Business Responsibility and Sustainability Report. 18 Apr - ELANTAS Beck India submitted its FY2025 Business Responsibility and Sustainability Report.
Frequently Asked Questions about Elantas Beck India Ltd
What does Elantas Beck India Ltd do?
ELANTAS Beck India Limited is engaged in manufacturing a wide range of specialty chemicals in the electrical insulation and construction industries. It is a part of ALTANA, an international specialty chemicals group. [1]
Where is Elantas Beck India Ltd (500123) listed?
Elantas Beck India Ltd is listed on the Indian stock exchanges. It is listed on NSE: ELANTAS and BSE: 500123. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Elantas Beck India Ltd belong to?
Elantas Beck India Ltd operates in the Commodities sector within the Chemicals & Petrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Elantas Beck India Ltd?
Elantas Beck India Ltd has a market capitalisation of approximately ₹7332.31 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Elantas Beck India Ltd?
The Price-to-Earnings (PE) ratio of Elantas Beck India Ltd is 50.39. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Elantas Beck India Ltd?
Over the past 52 weeks, Elantas Beck India Ltd has traded between a low of ₹8,900 and a high of ₹10,965. This range helps investors understand the stock's price volatility and recent trading levels.
Does Elantas Beck India Ltd pay dividends?
Yes, Elantas Beck India Ltd has a dividend yield of 0.08%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Elantas Beck India Ltd?
Elantas Beck India Ltd has a Return on Equity (ROE) of 14.66%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Elantas Beck India Ltd on Tapetide?
On Tapetide, you can view Elantas Beck India Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
ELANTAS Beck India Limited is engaged in manufacturing a wide range of specialty chemicals in the electrical insulation and construction industries. It is a part of ALTANA, an international specialty chemicals group. [1]
Website elantas.com/beck-india.html
Face Value ₹ 10